Key result
Epicardial patch glue repair for LV free wall rupture yields ~24% 30-day operative mortality.
Observational (n=17)
Answers are grounded in this paper and cite their sources.
BACKGROUND: Left ventricular free wall rupture (LVFWR) is a dramatic complication after myocardial infarction. We present our mid-term clinical and echocardiographic results of LVFWR with an epicardial patch without cardiopulmonary bypass. METHODS: From February 1993 to May 2001, 17 patients underwent surgery for LVFWR. The mean age+/-SD of 12 males and 5 females was 68+/-10 years. All patients presented for emergency surgery with cardiac tamponade confirmed on echocardiography. After opening the chest and identification of the site of rupture, a Goretex patch was fashioned and applied with enbucrilate surgical glue. RESULTS: Effective control of bleeding was achieved in all cases. There were no on-table deaths. The operative (30 day) mortality was 23.5% (4/17). One death occurred because of patch failure, two because of cardiogenic shock, and one from pneumonia. On follow-up at a median of 2.2 years (interquartile range, 1.1 to 4.3 years), two further deaths occurred, one from myocardial infarction and another of undetermined etiology. Echocardiography did not reveal any evidence of restriction to left ventricular free wall motion. CONCLUSIONS: Patch glue repair is expedient, simple and effective; with no adverse effects on mid-term ventricular dynamics. In view of superior published results to infarctectomy and repair with extra corporeal circulation, it should be considered to be the initial procedure of choice for the surgical repair of LVFWR.
No takes yet. Share an insight, caveat, or question.
Cánovas et al. (2003) conducted an observational in Left ventricular free wall rupture after myocardial infarction (n=17). Epicardial Goretex patch repair with enbucrilate surgical glue without cardiopulmonary bypass was evaluated on Operative (30-day) mortality. Epicardial patch glue repair for left ventricular free wall rupture achieved 100% bleeding control with a 23.5% (4/17) 30-day operative mortality and no mid-term wall motion restriction.
Synapse has enriched 10 related papers. Consider them for comparative context: